Randomized trial · people

Linaclotide raised weekly bowel movements in kids with constipation

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In a large placebo-controlled trial, linaclotide gave children aged 6-17 with functional constipation 1.17 more spontaneous bowel movements a week than placebo, with diarrhea as the main side effect.

Kind
Randomized trial
Studied in
People
Number studied
330
Published
2024
Journal
Lancet Gastroenterol Hepatol

What they tested

The team tested whether linaclotide works and is safe in children aged 6-17 with functional constipation.

How the study was done

A randomized, double-blind, placebo-controlled phase 3 trial at 64 sites in the USA, Canada, Israel, Italy, the Netherlands, Ukraine and Estonia. It enrolled 330 children aged 6-17, who took linaclotide 72 μg by mouth or a placebo (a dummy pill) once a day for 12 weeks; 328 who got at least 1 dose were analyzed.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Spontaneous bowel movements, meaning ones that happened without rescue medicine, rose by 2.22 per week in the linaclotide arm and by 1.05 per week on placebo, a difference of 1.17 per week (p<0.0001). Stool consistency also improved more with linaclotide than with placebo (change of 1.11 vs 0.69, p=0.0001). Diarrhea was the most common side effect on linaclotide, in 4% of children vs 2% on placebo. A 17-year-old girl on linaclotide had severe diarrhea that led to dehydration and a hospital stay, and it cleared up after IV fluids; no one died.

What it doesn’t show

The trial lasted 12 weeks and tested a single dose, so it does not show longer-term effects or how other doses compare. It was funded by AbbVie and Ironwood Pharmaceuticals.

The paper

Di Lorenzo et al. Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Gastroenterol Hepatol. 2024.

The compound

More studies on Linaclotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo